Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (R) 1 (4 bromophenyl) 2,2,2 trifluoroethanol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel biocatalytic route for (R)-1-(4-bromophenyl)-2,2,2-trifluoroethanol using Cyberlindnera saturnus. High ee, mild conditions, scalable pharma intermediate production.
Patent CN113462728A details a novel whole-cell biocatalytic route for high-purity chiral intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.